BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22132895)

  • 21. Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.
    Tiriveedhi V; Gautam B; Sarma NJ; Askar M; Budev M; Aloush A; Hachem R; Trulock E; Myers B; Patterson AG; Mohanakumar T
    J Heart Lung Transplant; 2013 Aug; 32(8):807-14. PubMed ID: 23856218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.
    Yoshida S; Haque A; Mizobuchi T; Iwata T; Chiyo M; Webb TJ; Baldridge LA; Heidler KM; Cummings OW; Fujisawa T; Blum JS; Brand DD; Wilkes DS
    Am J Transplant; 2006 Apr; 6(4):724-35. PubMed ID: 16539629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.
    Hachem RR; Tiriveedhi V; Patterson GA; Aloush A; Trulock EP; Mohanakumar T
    Am J Transplant; 2012 Aug; 12(8):2164-71. PubMed ID: 22568593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
    Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of autoimmunity in obliterative bronchiolitis after lung transplantation.
    Weber DJ; Wilkes DS
    Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L307-11. PubMed ID: 23262227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses.
    Sullivan JA; Jankowska-Gan E; Shi L; Roenneburg D; Hegde S; Greenspan DS; Wilkes DS; Denlinger LC; Burlingham WJ
    Am J Transplant; 2014 Jul; 14(7):1512-22. PubMed ID: 24866539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.
    Baskaran G; Tiriveedhi V; Ramachandran S; Aloush A; Grossman B; Hachem R; Mohanakumar T
    J Heart Lung Transplant; 2014 Sep; 33(9):950-6. PubMed ID: 24906794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients.
    Golocheikine A; Nath DS; Basha HI; Saini D; Phelan D; Aloush A; Trulock EP; Hachem RR; Patterson GA; Ahearn JM; Mohanakumar T
    J Heart Lung Transplant; 2010 Apr; 29(4):410-6. PubMed ID: 20022265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance.
    Yasufuku K; Heidler KM; Woods KA; Smith GN; Cummings OW; Fujisawa T; Wilkes DS
    Transplantation; 2002 Feb; 73(4):500-5. PubMed ID: 11889419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung.
    Yoshida S; Iwata T; Chiyo M; Smith GN; Foresman BH; Mickler EA; Heidler KM; Cummings OW; Fujisawa T; Brand DD; Baker A; Wilkes DS
    Transplantation; 2007 Mar; 83(6):799-808. PubMed ID: 17414715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
    SivaSai KS; Smith MA; Poindexter NJ; Sundaresan SR; Trulock EP; Lynch JP; Cooper JD; Patterson GA; Mohanakumar T
    Transplantation; 1999 Apr; 67(8):1094-8. PubMed ID: 10232557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.
    Bobadilla JL; Love RB; Jankowska-Gan E; Xu Q; Haynes LD; Braun RK; Hayney MS; Munoz del Rio A; Meyer K; Greenspan DS; Torrealba J; Heidler KM; Cummings OW; Iwata T; Brand D; Presson R; Burlingham WJ; Wilkes DS
    Am J Respir Crit Care Med; 2008 Mar; 177(6):660-8. PubMed ID: 18174545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
    Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML
    Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis.
    Velosa APP; Brito L; de Jesus Queiroz ZA; Carrasco S; Tomaz de Miranda J; Farhat C; Goldenstein-Schainberg C; Parra ER; de Andrade DCO; Silva PL; Capelozzi VL; Teodoro WR
    Front Immunol; 2020; 11():604602. PubMed ID: 33643291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral tolerance induction by type V collagen downregulates lung allograft rejection.
    Yasufuku K; Heidler KM; O'Donnell PW; Smith GN; Cummings OW; Foresman BH; Fujisawa T; Wilkes DS
    Am J Respir Cell Mol Biol; 2001 Jul; 25(1):26-34. PubMed ID: 11472972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung T-Cell Profile Alterations are Associated with Bronchiolitis Obliterans Syndrome in Cystic Fibrosis Lung Transplant Recipients.
    Hayes D; Harhay MO; Nicol KK; Liyanage NPM; Keller BC; Robinson RT
    Lung; 2020 Feb; 198(1):157-161. PubMed ID: 31807920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.